Post-Market Clinical Follow-up (PMCF) is the continuous process of collecting and evaluating clinical data on a medical device after it has received CE marking and is in real-world use. Under the EU Medical Device Regulation (EU) 2017/745 (MDR), the purpose is to confirm the device remains safe and performs as intended across its entire lifecycle.
How does PMCF fit within Post-Market Surveillance?
PMCF sits inside the broader Post-Market Surveillance (PMS) system. PMS covers all activities for monitoring a device on the market. PMCF is the part that focuses specifically on Clinical data: gathering real-world evidence, identifying new risks or side effects, and confirming the device maintains a favorable benefit-risk profile.
What activities count as PMCF?
PMCF activities include:
- Follow-up clinical investigations
- User surveys and questionnaires (PMCF Surveys and PMCF Studies are the two main service routes)
- Patient registries and case reviews
- Literature screening
- Analysis of complaints, incidents, and feedback from healthcare professionals
Why does PMCF matter for manufacturers?
Manufacturers are required to include a PMCF plan in their PMS plan, under MDR Article 61 and Annex XIV Part B. Findings must be analyzed and documented in a PMCF evaluation report, which feeds the clinical evaluation and the technical documentation. Results may in turn drive updates to risk management documentation, the PMS plan, and the Summary of Safety and Clinical Performance (SSCP).
Per MDCG 2020-8 guidance, PMCF is not optional. It is central to maintaining CE marking and protecting patient safety.
What is the aim of a PMCF plan?
A PMCF plan is designed to:
- Confirm the ongoing safety and performance of the device, including clinical benefits where applicable
- Detect previously unknown side effects or confirm known risks
- Identify and analyze emerging risks from real-world evidence
- Ensure the benefit-risk balance remains acceptable
- Detect any systematic misuse or off-label use of the device
Why PMCF is more than a compliance task
PMCF is more than a regulatory obligation. Done well, it strengthens your clinical evidence and surfaces real-world signals early enough to act on, safeguarding both compliance and patient outcomes throughout the device's life.
How Qserve helps with PMCF
Navigating PMCF under MDR can be complex. Qserve helps medical device manufacturers design and implement effective PMCF strategies that are compliant, practical, and matched to your device and risk profile, whether you're updating a clinical evaluation or building a PMCF plan from scratch.
Want to strengthen your clinical evidence and stay compliant under MDR? Explore our PMCF services or get in touch with our team.
Discover the top 5 reasons PMCF plans fail under MDR. Learn how MedTech manufacturers can design audit-ready PMCF strategies for Notified Body review.
Internal PMCF efforts often fall short under MDR. Learn what’s missing and how Qserve CRO helps MedTech manufacturers build audit-ready PMCF strategies.
Struggling with PMCF under EU MDR? Discover what works best for your team: in-house efforts or outsourcing to experts like Qserve.